HK1041518A1 - Lak activity-screening materials containing lenti nus extract of edodes mycelium and lak activity-screening methods using the extract. - Google Patents

Lak activity-screening materials containing lenti nus extract of edodes mycelium and lak activity-screening methods using the extract.

Info

Publication number
HK1041518A1
HK1041518A1 HK02101648A HK02101648A HK1041518A1 HK 1041518 A1 HK1041518 A1 HK 1041518A1 HK 02101648 A HK02101648 A HK 02101648A HK 02101648 A HK02101648 A HK 02101648A HK 1041518 A1 HK1041518 A1 HK 1041518A1
Authority
HK
Hong Kong
Prior art keywords
extract
lak activity
screening
nus
materials containing
Prior art date
Application number
HK02101648A
Other versions
HK1041518B (en
Inventor
Yukiko Matsuda
Yutaka Tajima
Kenji Asano
Original Assignee
Kobayashi Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharma filed Critical Kobayashi Pharma
Publication of HK1041518A1 publication Critical patent/HK1041518A1/en
Publication of HK1041518B publication Critical patent/HK1041518B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02101648.2A 1998-11-27 2002-03-04 Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract HK1041518B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35392698A JP4308350B2 (en) 1998-11-27 1998-11-27 LAK activity screening substance containing shiitake mycelium extract and LAK activity screening method using the same
PCT/JP1999/006615 WO2000033069A1 (en) 1998-11-27 1999-11-26 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same

Publications (2)

Publication Number Publication Date
HK1041518A1 true HK1041518A1 (en) 2002-07-12
HK1041518B HK1041518B (en) 2005-03-24

Family

ID=18434161

Family Applications (2)

Application Number Title Priority Date Filing Date
HK02101648.2A HK1041518B (en) 1998-11-27 2002-03-04 Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract
HK02104333.6A HK1042745A1 (en) 1998-11-27 2002-06-08 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK02104333.6A HK1042745A1 (en) 1998-11-27 2002-06-08 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same

Country Status (8)

Country Link
JP (1) JP4308350B2 (en)
KR (1) KR20010089498A (en)
CN (1) CN1314963C (en)
CA (1) CA2352614C (en)
GB (1) GB2360090B (en)
HK (2) HK1041518B (en)
TW (1) TWI222515B (en)
WO (1) WO2000033069A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101295444B1 (en) * 2011-12-22 2013-08-09 웅진식품주식회사 Novel microorganism for red ginseng fermenting, ferment solution and fermentative red ginseng drink using the same
CA2877338C (en) 2012-07-05 2022-10-11 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
JP5847106B2 (en) 2013-03-25 2016-01-20 株式会社フジキン Pressure flow control device with flow monitor.
EP4346861A1 (en) 2021-05-26 2024-04-10 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and moringa plant components

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2015294A1 (en) * 1989-04-28 1990-10-28 John J. Rinehart Generation and expansion of lak cells
US5198334A (en) * 1989-07-21 1993-03-30 Terumo Corporation Protection of natural killer cell cytolytic activity in peripheral blood mononuclear cells
US5108760A (en) * 1989-07-21 1992-04-28 Terumo Corporation Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
JP2002270532A (en) * 2001-03-14 2002-09-20 Tokyo Electron Ltd Heating device and thermal treatment apparatus

Also Published As

Publication number Publication date
CA2352614C (en) 2009-03-10
WO2000033069A1 (en) 2000-06-08
HK1042745A1 (en) 2002-08-23
JP4308350B2 (en) 2009-08-05
CA2352614A1 (en) 2000-06-08
JP2000162204A (en) 2000-06-16
HK1041518B (en) 2005-03-24
CN1332847A (en) 2002-01-23
GB2360090A (en) 2001-09-12
KR20010089498A (en) 2001-10-06
CN1314963C (en) 2007-05-09
GB2360090B (en) 2004-03-24
TWI222515B (en) 2004-10-21
GB0112999D0 (en) 2001-07-18

Similar Documents

Publication Publication Date Title
ZA986308B (en) The induction of stress-related factors in plants.
AU5454500A (en) Magnetically enhanced composite materials and methods for making and using the same
EP0592202A3 (en) D-ketohexose 3-epimerase, and its preparation and uses.
IL147803A0 (en) 28-epirapalogs
HK1020881A1 (en) Ccoa extract compounds and methods for making and using the same.
KR100201051B1 (en) The method for culturing cordyceps
ZA974786B (en) Sealed article.
EP0615964A3 (en) Aluminium nitride ceramics and method for preparing the same.
AU596780B3 (en) Packing case also usable for clothes-hanging and drawing purposes
AU1588497A (en) The extract of pine needle and the use thereof
DE68923434D1 (en) Composite particles.
EP0587777A4 (en) Cea-binding proteins and methods for their isolation and use.
AU3327097A (en) Laminate, process for its preparation and its use
AU3974989A (en) Sequence-specific amplification techniques
HK1041518A1 (en) Lak activity-screening materials containing lenti nus extract of edodes mycelium and lak activity-screening methods using the extract.
EP0444605A3 (en) Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof
GB2359561B (en) LAK activity enhancers derived from extract of Lentinus edodes mycelium and LAKactivity-enhancing formulations containing the extract
GB2359562B (en) gamma delta T cell immunoactivity enhancers containing extract of Lentinus edodes mycelium
AU2708597A (en) An improvement in the treatment of wastes
FR2593149B1 (en) CONTAINER WATERPROOF.
ZA977608B (en) Treatment of materials to improve handling of viscoelastic fluids.
GB9617124D0 (en) Improvement in the lavatory
AUPN903596A0 (en) The use of antibodies against CD48 for the treatment T and B cell lymphomas and leukemias
AU2143597A (en) The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
AUPN896296A0 (en) The use of antibodies against cd48 for the treatment t and b cell lymphomas and leukemias

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAMES OF THE INVENTORS FROM HITOSHI NAGAOKA AND KOBAYASHI PHARMACEUTICAL CO LTD TO YUKIKO MATSUDA, YUTAKA TAJIMA AND KENJI ASANO

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101126